ksunn

Celosia Therapeutics CEO and Director of Commercialisation at Macquarie University, Dr Kathryn Sunn sit down for an interview post the company’s landmark Series A funding… Read More »Video – Interview with Celosia Therapeutics CEO Dr Kathryn Sunn

Sydney, Australia, 28 November 2024 – Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, has completed one of the largest… Read More »Celosia Secures Landmark $16.75M Funding for Breakthrough ALS Gene Therapy